Why is Zeaxanthin the Most Concentrated Xanthophyll in the Central Fovea?
Level 5 - mechanism / opinion, no new human data
Narrative review synthesizing mechanistic and biophysical literature
PubMed 32392888 · doi:10.3390/nu12051333
What was done
This narrative review evaluates literature on the biological, biophysical, and biochemical mechanisms explaining how dietary xanthophylls (zeaxanthin and lutein) and meso-zeaxanthin are transported, sequestered, and bioamplified differentially across the human retina, with a focus on the central fovea.
What was found
Dietary xanthophylls accumulate in the central retina at concentrations around 1 mM. In the cone-dense central fovea, zeaxanthin concentrations are 2.5-fold higher than lutein, representing an approximately 20-fold increase in the molar ratio of zeaxanthin to lutein relative to eccentric retinal regions.
Why it matters
Clarifying the specific biophysical properties and regional distribution of zeaxanthin helps explain how macular carotenoids protect the vulnerable central fovea from oxidative stress and light-induced damage involved in age-related macular degeneration.
Limits
This is a narrative review that provides no new experimental data or systematic review methodology. Specific search parameters, quantitative syntheses, and sample sizes of the cited studies are not provided in the abstract.
Cited by
- supports Randomized controlled trials show that lutein and zeaxanthin accumulate in the eye and can help prevent age-related macular degeneration.